chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started feeling nausea, chills arm was red and swollen.  The chills got worse and worse - highest temperature recorded was 100.2.
Nausea, vomiting, pain and swelling at injection site, fever, loss of appetite.
FOOD LODGING ON THE THROAT AND CAUSES TROUBLE BREATHING; THROWING UP AFTER EATING ANY TYPE OF FOOD; COUGH; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol use (1 glass on the weekends), and non-smoker, and other pre-existing medical conditions included: The patient had no relevant medical history and no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: UNKNOWN) dose was not reported, administered on 18-OCT-2021 for prophylactic vaccination. No concomitant medications were reported.  On 21-OCT-2021, the patient experienced cough. On 01-NOV-2021, the patient experienced food lodging on the throat and causes trouble breathing, and throwing up after eating any type of food. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from cough, throwing up after eating any type of food, and food lodging on the throat and causes trouble breathing. This report was non-serious.
No adverse effect, vaccine was administered after expiry which was 9/30/22. but per Pfizer vaccine is stable until 10/19/22
Rash at injection site - took Benadryl for 2 days, rash dissipated after 7 days Also odd reaction - lower left leg below knee now has a tingling numbness feeling occasionally,  started the day after injection, has not gone away.  It is the same leg as the toe that has a nail fungal infection
High fever 104.3 crying lethargic only sleep on someone Tylenol every 4 hours not keeping fever away. Vomiting diarrhea went to 3 ER's before being admitted on 12/29/2015 diagnosed with Kawasakis disease recieved IVIG treatment.
Terrible pain, heachace, worst flu like symptoms, chills, fever, sweats, loss of energy, 24 hours, slept all day, very uncomfortable, 2nd day 30% better, still headache, achy
Feeling dizzy, nauseated, sweaty and lightheaded. Vital signs checked and monitored. Feeling better lying down. At 10:30, approximately 10 minutes after sent to observation room, felt better. B/P 120/70; HR 61; O2 Sat 98. Client went home.
I had a weird pin poke feeling periodically in my right back side of my arm almost right away.  It dissipated after an hour or two.  There was a large (6") oval shaped red irritated area and a lump feeling on my upper right arm that started soon after the injection and got worse over the next few days.  It faded about a week or week and a 1/2 later.  The more significant problems started overnight the 24th and lasted quite some time. Beginning the 24th,  I felt like I had a very bad internal bruise inside my armpit and swelling in my armpit and shoulder. My right shoulder, arm, elbow wrist and  and down to my fingtertips (mostly the pinky, ring, and middle) all began t ached very badly and the 25th and also felt numb at the same time.     I couldn't sleep. Advil, CBD topicals, and ice, together, never helped fully.  Used ice pack on front and back of elbow/upper arm, wrist  and switching with neck.  Made dr appt Tuesday the 27th for soonest available with PA on September 10.  Called doctor on the 27th due to the pain not receding, but getting worse, but no appt until October. scheduled with PA for Sept 10, but that seemed a long time away for the amount of pain.
patient received dose of Moderna vaccine post excursion; patient received dose of Moderna vaccine post excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion).    Concomitant medication was not reported. Treatment drug was not reported. This case contains information for the 9th of 19 patients reported by the reporter   This case was linked to US-MODERNATX, INC.-MOD-2023-706941 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-706941:Patient 1 of 19
Felt throat swollen with a stuffy nose; Felt throat swollen with a stuffy nose; stabbing chest pains; stomach pains; stabbing pains all over body in different areas; pain in my carotids; pain behind ears; headaches; This is a spontaneous report from a contactable other-HCP. A 40-year-old female Other-HCP (patient) reported for herself. The patient received the first dose of BNT162B2 (COMIRNATY, Formulation: Solution for injection, Lot Number: ER8730) via an unspecified route of administration, administered in left arm on 28Mar2021 12:15 (at the age 40-year-old) as dose 1, single for COVID-19 immunization. The patient medical history was included, seasonal allergies. The patient concomitant medications included ibuprofen (IBUPROFEN; cetirizine (CETIRIZINE); albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]). The patient was non-pregnant. On 28Mar2021 12:45 the patient experienced Felt throat swollen with a stuffy nose, got stabbing chest pains and stomach pains the day of injection, also have stabbing pains all over body in different areas that happen randomly that still currently happen. Have also currently pain in my carotids, pain behind ears, and have headaches every day. The patient was not covid prior vaccination and not covid tested post vaccination. The events were reported as non-serious. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
It is itchy and firm. She has been using a hydrocortisone cream and tylenol so far. It is warm to the touch. it is increasing in size.
She had a red hot lump under her left arm along with a lump on her arm where the vaccine was administered. These symptoms lasted for 3-4 days
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Nov2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 67 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "BPH" (unspecified if ongoing); "cataracts" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 29Apr2023 to 03May2023. Patient did not have known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300187540 Same patient, different drug/ events;
hives devel about 5hr p/vax spreading across shoulders, neck & back & a rash appeared on abd;the hives manifested as a bumpy, faintly itchy skin condition that peaked in about 24hr but took a wk to subside altogether;
fatigue; not much of an appetite; headaches; chills; dizziness; felt febrile/fever; arm soreness after the injection; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899) via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications was not reported. The patient was social worker who received the Covid 19 vaccine on 22Dec2020. She reported some arm soreness after the injection on 22Dec2020. On Wednesday (23Dec2020), she began having dizziness and felt febrile, On Thursday (24Dec2020) she reported a fever of 100.6, fatigue extreme, not much of an appetite, headaches and chills. She states the fever has gone away for the most part but she isn't always checking. She was alternating Tylenol and Advil. Wanted to know about if these symptoms was normal post vaccination and how long they will last. It's been few days now. Treatment was received for all events. The outcome of the events was unknown.
Itching on and off at the injection location; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on and off at the injection location) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PRURITUS (Itching on and off at the injection location). At the time of the report, VACCINATION SITE PRURITUS (Itching on and off at the injection location) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Flu B; patient had Flu B and this year's shot was pretty worthless; Initial information received on 09-Oct-2020 regarding an unsolicited valid serious social media case received from a consumer or non-healthcare professional. This case involves a male patient (age not reported) who experienced flu B (influenza), while he received INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed flu B (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event.  It was also a case of vaccination failure, the reporter mentioned that this year's shot was pretty worthless.  Relevant laboratory test results included: Influenza B virus test - On an unknown date: Positive  It was not reported if the patient received a corrective treatment.  At the time of reporting, outcome was unknown for influenza.  There will be no information available on the batch number for this case.; Sender's Comments: This case involves an adult male patient who experienced influenza despite of vaccination with INFLUENZA VACCINE. The time to onset was unknown. However, patient's medical condition at time of vaccination was not reported. Based upon the reported information the role of suspect vaccine cannot be assessed.
ADR occurred covid vaccination clinic on 1/27/21. Employee received covid 2nd vaccination (Moderna Lot 013L20A, Exp 07/08/21) on 1/27/21. Reaction reported 1/29/21 documented left arm red, swelling warmth at covid vaccine site.  Patient was recommended to be seen by physician following Monday for medical evaluation if symptoms continued.  Per documentation in Athena, 1/29/21 patient received a one time diphenhydramine 50mg injection, with instruction to start ice pack.
From telephone contact received at manufacturer on 08/14/2002 it was reported that a 48-year-old female received Imovax and Imogam started on 07/23/2002 as a post exposure treatment. The pt experienced generalized muscle aches, malaise after each dose. After third dose Imovax received on 07/30/2002, she developed bilateral facial pain (more right sided than left), generalized muscle and joint aches. After the 4th dose, on 08/16/2002, she experienced exacerbation of pain and tightness in face, which has not improved. The neurologist was contacted today, 08/14/02. The neurologist stated that it's not neurological in nature but most likely vaccine related. The pt contacted the CDC and was recommended to complete last dose of series with another rabies vaccine.
afterwards he had pain from shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6205, Expiry date: not provided), via an unspecified route of administration on 17Mar2021 at the age of 72-years-old as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, NDC number and Expiry date are unknown, Lot Number: EL9265), via an unspecified route of administration on 24Feb2021 at the age of 72-years-old as single dose for covid-19 immunisation. Investigations were not provided. The patient said that he got Pfizer COVID-19 shots and two weeks afterwards he had pain from shingles on an unspecified date. The reporter said he has a complaint about Pfizer COVID-19 vaccine side effect of shingles after, he wants to know a response about the vaccine, he got the second dose of the vaccine 19Mar2021, later clarified to being 17Mar2021. He says the shingles are a very painful experience, he has seen many people on the internet have incidence due to Pfizer vaccine issue. He doesn't provide any further details about what he saw on the internet and doesn't clarify what he meant by issue. He says he gave his details to someone who said that someone would call him back, but no one has in the last four or five days. He said he got his first vaccine dose on 15Feb2021, clarified to 24Feb2021, of LOT: EL9265 at location (Name). NDC queried but not provided, he says there is no expiry date provided on the vaccine card for either dose. He said three weeks later on 17Mar2021, he got his second dose which was LOT: EN6205. He said something about suffering from excruciating pain of shingles, unable to clarify with patient. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Pt. states that after receiving the 2nd dose of Moderna 05/29/2021, started experiencing symptoms 05/30/2021 of Welp with lump at injection site continuing, soreness, numbness throughout the arm radiates down to the elbow and fingers. Tingling (needles) in the fingers. Still continuing no noted Primary visit.
VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins); This non-serious spontaneous report with reference numbers 02197725 / 02197588 was received by partner on 05-JUL-2022 and forwarded on 06-JUL-2022 from a consumer.    The causal relationship between Vaxelis and the reported event "multiple doses of VAXELIS administered since temperature excursion" was assessed as not applicable due to the nature of the event.    Further information is expected.  FOLLOW-UP INFORMATION was received by a partner on 01-AUG-2022 and forwarded on 03-AUG-2022, from a HCP.   The case is maintained as non-serious.  The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient.  Due to the nature of the event, the causality between the event "VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins)" and Vaxelis remained not applicable.  For reference purposes this case is linked to  MCM-003724, MCM-003725, MCM-003726, MCM-003729, MCM-003734, MCM-003735, MCM-003737, MCM-003738, MCM-003739, MCM-003740, MCM-003741, MCM-003742, MCM-003743, MCM-003744, MCM-003747, MCM-003749, MCM-003751, MCM-003752, MCM-003753, MCM-003757, MCM-003759, MCM-003761, MCM-003763, MCM-003766, MCM-003767, MCM-003769, MCM-003770, and MCM-003772, due to same reporter.  No further information is expected.
Swelling, redness in the administration area and all of bicep. Pt reported "tingling" up to neck and down through entire arm. Pt also reported she felt "itchy" in affected area.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not provided. On unknown dates, the patients were vaccinated with GARDASIL lot # K008931, expiration date 04-MAR-2017 (route was not provided). Concomitant therapy information was not provided. On unknown dates, there was incorrect product storage as improperly stored GARDASIL was administered to unspecified patients. There was no adverse event. It was unknown if the patients sought medical attention. At th time of the report, the patients' status was unknown. The outcome of incorrect product storage and no adverse event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Soreness, swelling in left arm, even after drinking 1l of water, putting ice on area, and taking Tylenol 1000mg.
Initial report received from a consumer (patient's relative) on 21 May 2010: This patient was vaccinated with S-OIV FLUVIRIN (influenza virus vaccine monovalent, batch number 10073803), 0.5 ml, intramuscular, on 21 Nov 2009. After vaccination, platelet level of the patient decreased to 35, 36 (unit and reference value unknown) on 29 Dec 2009. it was diagnosed as idiopathic thrombocytopenic purpura. Final outcome of the event was reported as condition unchanged.
Shingles; sores and pain; This is a spontaneous report from a contactable Other-HCP (patient).  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunisation. The patient medical history included ongoing lupus erythematosus. Concomitant medication included belimumab (BENLYSTA), intravenous from an unspecified date (after the vaccine) at unspecified dosage for systemic lupus erythematosus. The patient experienced shingles, sores and pain on 06Jan2021 with outcome of unknown.  The action taken for belimumab was unknown. She would like to know if her first dose of the vaccine was still effective and if she should receive her second dose of the vaccine on 23Jan2021.  Information about lot/batch number has been requested.
3/30/2022 at 0747 Employee notified the Nurse Vaccine Support line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date - 3/28/2022 Booster Dose - Yes Location - Right Deltoid Date of Symptom Onset - 3/28/2022 (Night of ) Symptoms - Fever (Tmax 102F), Headache, Left Axilla Pain, Tenderness at Injection Site, Body Aches (Last Fever on 3/29/22) Last Day of Work and Shift - 3/28/2022 (Regular shift Days) Home Remedies - Ibuprofen 600 mg twice, Warm compress (Unable to do cold due to comorbid - Sickle Cell) Any Improvement - Yes (Fever subsided), however, R arm tenderness remains
Pt received shingles vaccine around 1530 or so. Developed tingling in  lips afterwards so was watched by pharmacy. Those sx resolved but pt then  developed headache, nausea, and felt light headed. She vomited a few times at  home. Denies lip, perioral/tongue swelling, difficulty swallowing, dyspnea,  wheezing.    sx completely resolved with symptomatic treatment below. Discussed  return precautions.   ORDERS FOR TODAY:   SODIUM CHLORIDE 0.9% INJ,SOLN  1000 ml IV BOLUS@0   DIPHENHYDRAMINE INJ,SOLN   25MG/0.5ML IVP NOW   ONDANSETRON INJ,SOLN   4MG/2ML IVP NOW for nausea and vomiting   KETOROLAC TROMETHAMINE INJ   15MG/0.5ML IV PUSH NOW
Flu shot given 9-25-13. Pt said arm sore, no redness. Put heating pad on it. 9-26-13 not really red, not a lot of pain. Felt better. Put heating pad on again. 9-27-13 came to pharmacy. Said it felt good not hurt. Arm was red, slightly raised. Little warm. Advised to take BENADRYL. Apply cool compress. 9-28-13 arm not as red but redness looked larger. Not hurt. Advised pt to apply cool compress, take BENADRYL and if no better - go to PCP or urgent care. 9/30 pt says arm is fine.
Patient received a PNEUMOVAX shot 10/17/2017, noticed redness and swelling at injection site and pain. Patient spoke to pharmacist on 10/18/2017 who advised her that if the pain continues for another day and redness then she should see a physician or other qualified health provider. Patient did not feel better, her arm worsened in pain and redness. She saw healthcare provider who admitted her to the hospital and is treating her with antibiotics and fluids.
Narrative: Headache, Arthralgia, Fatigue, chills, injection site pain and swelling.
Case number PHEH2015US026592, is a spontaneous report initially received from a medical assistant on 16 Dec 2015. This report refers to a 64 years old female patient. Past vaccination history included FLUVIRIN was tolerated in the past. Concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515301) at a dose of 0.5 ml intramuscularly on 14 Dec 2015 at 16:00 hours which was stored above the recommended temperature range. No adverse event reported following this medication errors (incorrect storage of drug). The medication error was reported as non serious. Reporter stated that FLUVIRIN was not above the normal range parameters and patient was doing fine. Reporter would fill out the follow up form. Follow up report received from health care professional on 09 Feb 2016: Updated reporter's comment. Follow up information received from health care professional (medical assistant) on 23 Feb 2016: Updated batch number, added vaccination history, time and site of vaccination.
Pt. had 3 cm raised area at injection site slightly tender to touch, minimal bruising appears to be hematoma.